Biostem Technologies Inc (BSEM) stock news · P/E 8.5, rev $14.0M
Biostem Technologies Inc (BSEM) is a biotechnology company listed on US.
This BSEM news page leads with what Biostem Technologies Inc filed — not a scraped headline mill.
No cached 8-K sentence for BSEM yet. We will not pad this page with generic market recap.
Latest reported BSEM revenue for 2026-06-30 was $14.0M. Net income was -$17.8M. Revenue was down 47.9% from 2025-06-30 to 2026-06-30. BSEM currently screens at market cap $211.2M and trailing P/E 8.5.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the BSEM stock page; for the tape open the quote page.
Not investment advice.